BioCentury
ARTICLE | Financial News

AtheroGenics to raise $75 million

August 12, 2003 7:00 AM UTC

AGIX plans to raise $75 million through the sale of convertible notes due 2008. The company's lead compound, AGI-1067, is in Phase III testing for atherosclerosis. AGIX, which made the announcement af...